Skip to main content
Premium Trial:

Request an Annual Quote

IntelligentMDx Gets Canadian ISO Certification

NEW YORK (GenomeWeb News) – IntelligentMDx today said that it has gained ISO certification from Canadian authorities to develop and manufacture its molecular diagnostic tests at its facilities in Cambridge , Mass., where the firm is based.

IMDx said that it underwent an audit of its quality system to ISO 13485:2003 with the implementation of requirements from the Canadian Medical Devices Regulations. The accreditation was received from the Laboratoire national de métrologie et d'essais and will enable the firm to seek licenses to commercialize its tests in Canada.

IMDx's portfolio includes CE-marked tests for toxigenic Clostridium difficile, vancomycin-resistant enterococci, and Group B streptococcus. It also is developing assays for herpes simplex virus 1 and 2, influenza A/B and respiratory syncytial virus, Epstein-Barr virus, and BK virus.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.